The Generic Injectable Market is anticipated to reach US$ 3,22,433.1 million in value by 2033, expanding at a CAGR of 11.6% from 2023 to 2033. In 2023, it is projected that the market will be worth US$ 1,07,419.72 million. The global market for generic injectables is anticipated to reach US$ 85 billion in 2021, according …
Category Archives: Healthcare Trends
Animal Artificial Insemination Market is expected to surpass US$ 3.6 Billion and grow at 5.5% CAGR through 2032
The Animal Artificial Insemination Market is anticipated to surpass US$2.11 billion in 2022. The artificial insemination market for animals is projected to grow to more than US$3.6 billion by 2032. The market for animal artificial insemination is anticipated to grow at a CAGR of 5.5% from 2018 to 2032. The market for animal artificial insemination …
Corneal Ulcer Treatment Market is expected to reach US$ 1.27 Billion by end of 2029 at a CAGR of 5.7%
The Corneal Ulcer Treatment Market is anticipated to develop as a result of rising contact lens usage, novel treatment options, such as anti-amoebic medications, and well-established supply chain operations. The market for corneal ulcer therapy is expected to grow significantly at 5.7% CAGR from 2022 to 2029, reaching an estimated market value of about US$ …
Japan’s Veterinary Biologics Market is offering lucrative growth opportunities and is expected to exhibit healthy growth of 6.8% CAGR from 2022 to 2029
A recent market analysis by Future Market Insights (FMI) projects that the global Veterinary Biologics Market will be worth US$ 11.4 billion in 2022 and US$ 18.2 billion by 2029. Pet health concerns are on the rise due to the growing trend of pet ownership around the world, which is driving up demand for veterinary …
Therapeutic Nuclear Medicines Market is projected to increase from a valuation of US$ 1 Billion in 2022 | FMI
Increasing acceptance of therapeutic nuclear medicines (or radiopharmaceuticals) among industry experts will remain a prominent factor in encouraging their adoption. Though associated with a negligible risk factor, radiopharmaceuticals are likely to witness growing recommendations owing to no proven significant adverse effects. In the backdrop of the growing criticality of a more reliable, safer, and lesser …
Vulvovaginal Candidiasis Treatment Market is Likely to Witness Steady Growth, anticipated to Reach US$ 1607 Million by 2033 | Future Market Insights, Inc.
The global Vulvovaginal Candidiasis Treatment Market is currently valued at US$ 1035 Million in 2023 and is anticipated to expand at a CAGR of 4.5%. Owing to the technological advances in healthcare sector the market is likely to propel to US$1607 Million by 2033. VVC prevalence has increased due to growing diabetes cases and repeated antibiotic usage among individuals. The …
Lyophilized Injectable Market is currently valued at US$ 3043.55 Million in 2023 | FMI Study
The global Lyophilized Injectable Market is expected to grow at a steady 5.8% over the next few years. In 2023, the lyophilized injectable market is expected to be worth $3043.55 million. Demand for lyophilized injectables is expected to reach a peak of US$ 5348.56 Mn by 2033. Because of their stability at room temperature, lyophilized medications are …
Kaempferol Market is projected to grow at a CAGR of 4% from 2022 to 2032 | FMI Study
[342 Pages Report] The kaempferol market, which was valued at US$ 3.91 billion in 2022, is expected to grow at a CAGR of 4% during the forecast period, reaching US$ 5.79 billion by 2032. Kaempferol provides excellent benefits like reducing the risk of chronic diseases like cancer, strengthening anti-oxidant defense against free radicals, offering resistance against …
Non-Hyaluronic Acid Dermal Filler Market is predicated to increase at a CAGR of 2.6% from 2022 to 2032 | FMI Study
The global non-hyaluronic acid dermal filler market size is expected to reach US$ 520.4 Million by 2032. As per FMI Analysts, the global non-hyaluronic acid dermal filler market is estimated to be valued at US$ 392.7 Million in 2022 and is projected to increase at a CAGR of 2.6% from 2022 to 2032. Cosmetic plastic surgery is commonly used these days, as it …
eClinical Solutions and Software Market is anticipated to reach a valuation of US$ 29.1 Billion in 2033
The global eClinical solutions and software market is anticipated to reach a valuation of US$ 29.1 billion in 2033, rising up from an estimated US$ 9.3 billion in 2023. Valued at US$ 8.4 billion in 2022, the market witnessed a CAGR of 10.6% from 2017 to 2022. It is gauged that the eClinical solutions and …